Guardant Health
GH
#1965
Rank
NZ$17.66 B
Marketcap
NZ$134.64
Share price
-9.83%
Change (1 day)
91.01%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company